Free Trial
TSE:EDT

Spectral Medical (EDT) Stock Price, News & Analysis

Spectral Medical logo
C$0.50 -0.02 (-3.85%)
(As of 11/21/2024 ET)

About Spectral Medical Stock (TSE:EDT)

Key Stats

Today's Range
C$0.50
C$0.52
50-Day Range
C$0.50
C$0.67
52-Week Range
C$0.37
C$0.75
Volume
338,903 shs
Average Volume
82,471 shs
Market Capitalization
C$140.63 million
P/E Ratio
N/A
Dividend Yield
1.45%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.

Receive EDT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Spectral Medical and its competitors with MarketBeat's FREE daily newsletter.

EDT Stock News Headlines

The top TSX healthcare stocks under $1
Spectral Medical Nears Completion of Tigris Trial
Central Bank Abandons USD
You know what doesn't care about elections? Gold. If you want to protect your savings & retirement from our exploding national debt, VOTE FOR GOLD!
Spectral Medical Provides September Tigris Trial Update
12 Horrifyingly Haunted Hotels You Can Actually Stay at—If You Dare
See More Headlines

EDT Stock Analysis - Frequently Asked Questions

Spectral Medical's stock was trading at C$0.43 at the beginning of 2024. Since then, EDT stock has increased by 17.6% and is now trading at C$0.50.
View the best growth stocks for 2024 here
.

Spectral Medical Inc. (TSE:EDT) released its quarterly earnings data on Friday, November, 8th. The company reported ($0.04) earnings per share for the quarter. The business earned $0.50 million during the quarter.

Shares of EDT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Spectral Medical investors own include Oncolytics Biotech (ONC), Aurora Cannabis (ACB), Alamos Gold (AGI), BlackBerry (BB), Ballard Power Systems (BLDP), CENTRIC HEALTH (CHH) and Cequence Energy Ltd. (CQE.TO) (CQE).

Company Calendar

Last Earnings
11/08/2024
Today
11/22/2024
Next Earnings (Estimated)
3/27/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
29
Year Founded
N/A

Profitability

Net Income
C$-18,680,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$1.90 million
Cash Flow
C$0.01 per share
Book Value
C($0.08) per share

Miscellaneous

Free Float
N/A
Market Cap
C$140.63 million
Optionable
Not Optionable
Beta
0.96
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

This page (TSE:EDT) was last updated on 11/22/2024 by MarketBeat.com Staff
From Our Partners